Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 13 Pharmacy (local) PhD Projects, Programmes & Scholarships

Discipline

Discipline

Medicine

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


Pharmacy (local) PhD Projects, Programmes & Scholarships

We have 13 Pharmacy (local) PhD Projects, Programmes & Scholarships

Microfluidic technologies applied to respiratory diseases

Subject area. 3D Printing, lab-on-a-chip, Drug Delivery, Pharmaceutical Technology. In Preclinical studies, a large number of molecules and biomolecules, in a very short time, have to be evaluated in terms of efficacy and toxicity. Read more

Novel strategies and innovative technologies to produce amorphous solid dispersion

Poor drug solubility presents a major challenge in drug product development of oral solid dosage (OSD) forms. However, many new development compounds exhibit poor solubility and only a few of them reach market approval. Read more

MICROFLUIDIC TECHNOLOGIES FOR THE PRODUCTION OF NANOMEDICINES

Progress in drug design has led to the development of new molecules. However, the limited ability to selectively deliver these molecules at well-defined dosing regimens remains a significant challenge. Read more

3D & 4D PRINTING IN CANCER MANAGEMENT

According to WHO, cancer is the second leading cause of death worldwide, with nearly 1 in 6 deaths been due to cancer. The principal modes of cancer management are surgery, radiotherapy, chemotherapy and pharmaceutical agents. Read more

Development of Nanomaterials for Targeting the Bacteria–Host Interface in Cystic Fibrosis Airways

The attachment of Pseudomonas aeruginosa (PA) to the airway mucus in the lungs of people with cystic fibrosis (CF) represents an important step in airway colonization and the subsequent development of lung infection. Read more

Assessing the molecular mechanisms by which Cathepsin V promotes breast cancer growth and metastasis

Targeted therapies such as tamoxifen, fulvestrant and anastrozole have exhibited significant clinical success since being introduced as treatments for Estrogen Receptor positive (ER+) breast cancer patients. Read more
  • 1

Filtering Results